277 related articles for article (PubMed ID: 8356934)
21. Pharmacokinetic comparability of Prolastin®-C to Prolastin® in alpha₁-antitrypsin deficiency: a randomized study.
Stocks JM; Brantly ML; Wang-Smith L; Campos MA; Chapman KR; Kueppers F; Sandhaus RA; Strange C; Turino G
BMC Clin Pharmacol; 2010 Sep; 10():13. PubMed ID: 20920295
[TBL] [Abstract][Full Text] [Related]
22. [Practical applications of recombinant alpha-1-antitrypsin in medicine].
Kabziński J; Kedziora J; Majsterek I
Pol Merkur Lekarski; 2010 Dec; 29(174):345-50. PubMed ID: 21298982
[TBL] [Abstract][Full Text] [Related]
23. Reduction of severe exacerbations and hospitalization-derived costs in alpha-1-antitrypsin-deficient patients treated with alpha-1-antitrypsin augmentation therapy.
Barros-Tizón JC; Torres ML; Blanco I; Martínez MT;
Ther Adv Respir Dis; 2012 Apr; 6(2):67-78. PubMed ID: 22354900
[TBL] [Abstract][Full Text] [Related]
24. A review of alpha-1 antitrypsin deficiency.
Ranes J; Stoller JK
Semin Respir Crit Care Med; 2005 Apr; 26(2):154-66. PubMed ID: 16088434
[TBL] [Abstract][Full Text] [Related]
25. Prolastin, a pharmaceutical preparation of purified human alpha1-antitrypsin, blocks endotoxin-mediated cytokine release.
Nita I; Hollander C; Westin U; Janciauskiene SM
Respir Res; 2005 Jan; 6(1):12. PubMed ID: 15683545
[TBL] [Abstract][Full Text] [Related]
26. Alpha 1-PI for emphysema due to alpha 1-antitrypsin deficiency.
Horowitz ID; Schulman ES
Am Fam Physician; 1989 Sep; 40(3):223-8. PubMed ID: 2672752
[TBL] [Abstract][Full Text] [Related]
27. [Difficulties in controlled inhalation of alpha 1-protease inhibitor].
Brand P; Maas Enriquez M; Meyer T; Scheuch G; Weber N
Pneumologie; 2003 Mar; 57(3):153-8. PubMed ID: 12632295
[TBL] [Abstract][Full Text] [Related]
28. α1-Antitrypsin Deficiency.
Hatipoğlu U; Stoller JK
Clin Chest Med; 2016 Sep; 37(3):487-504. PubMed ID: 27514595
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of augmentation therapy for emphysema associated with α1-antitrypsin deficiency: enough is enough.
Balbi B; Ferrarotti I; Miravitlles M
Eur Respir J; 2016 Jan; 47(1):35-8. PubMed ID: 26721962
[No Abstract] [Full Text] [Related]
30. A pilot study comparing the purity, functionality and isoform composition of alpha-1-proteinase inhibitor (human) products.
Cowden DI; Fisher GE; Weeks RL
Curr Med Res Opin; 2005 Jun; 21(6):877-83. PubMed ID: 15969888
[TBL] [Abstract][Full Text] [Related]
31. Augmentation therapy in alpha-1 antitrypsin deficiency.
Heresi GA; Stoller JK
Expert Opin Biol Ther; 2008 Apr; 8(4):515-26. PubMed ID: 18352854
[TBL] [Abstract][Full Text] [Related]
32. Alpha-1 antitrypsin deficiency: pathogenesis, clinical presentation, diagnosis, and treatment.
Köhnlein T; Welte T
Am J Med; 2008 Jan; 121(1):3-9. PubMed ID: 18187064
[TBL] [Abstract][Full Text] [Related]
33. The efficacy and safety of inhaled human α-1 antitrypsin in people with α-1 antitrypsin deficiency-related emphysema.
Franciosi AN; McCarthy C; McElvaney NG
Expert Rev Respir Med; 2015 Apr; 9(2):143-51. PubMed ID: 25598013
[TBL] [Abstract][Full Text] [Related]
34. Clinical features and molecular characteristics of alpha 1-antitrypsin deficiency.
Blank CA; Brantly M
Ann Allergy; 1994 Feb; 72(2):105-20; quiz 120-2. PubMed ID: 8109800
[TBL] [Abstract][Full Text] [Related]
35. Prolastin aerosol therapy and sputum taurine in cystic fibrosis.
Cantin AM; Berthiaume Y; Cloutier D; Martel M
Clin Invest Med; 2006 Aug; 29(4):201-7. PubMed ID: 16986483
[TBL] [Abstract][Full Text] [Related]
36. Alpha-1 Antitrypsin Therapy in Cystic Fibrosis and the Lung Disease Associated with Alpha-1 Antitrypsin Deficiency.
McElvaney NG
Ann Am Thorac Soc; 2016 Apr; 13 Suppl 2():S191-6. PubMed ID: 27115956
[TBL] [Abstract][Full Text] [Related]
37. alpha-1-Antitrypsin ameliorates cigarette smoke-induced emphysema in the mouse.
Churg A; Wang RD; Xie C; Wright JL
Am J Respir Crit Care Med; 2003 Jul; 168(2):199-207. PubMed ID: 12689849
[TBL] [Abstract][Full Text] [Related]
38. [Expert statement for augmentation therapy in patients with alpha-1 antitrypsin deficiency].
Köhnlein T; Schmidt-Scherzer K; Greulich T; Bals R
Pneumologie; 2014 Jul; 68(7):492-5. PubMed ID: 25006842
[TBL] [Abstract][Full Text] [Related]
39. [New therapeutic possibilities in alpha 1-antitrypsin deficiency].
Kok-Jensen A; Dirksen A; Evald T; Keittelmann S; Viskum K
Ugeskr Laeger; 1990 Mar; 152(13):906-8. PubMed ID: 2181756
[TBL] [Abstract][Full Text] [Related]
40. Comment: comparisons of Aralast and Prolastin, alpha1-protease inhibitors for treatment of alpha1-antitrypsin deficiency.
Petteway SR
Ann Pharmacother; 2006 Feb; 40(2):353-4; author reply 354. PubMed ID: 16449545
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
